According to FutureWise analysis the market for anthrax treatment in 2023 is US$ 0.6 billion, and is expected to reach US$ 1.08 billion by 2031 at a CAGR of 7.60%.
It mainly affects farm animals but can infect humans through contact with contaminated animals or their products and even through heroin injection. Laboratory workers and those potentially exposed to bioterrorism are also at risk. Notably, anthrax is not contagious, requiring swift medical attention upon exposure. The infection is caused by Bacillus anthracis bacteria, which form spores in soil, remaining viable for years. Upon entry into the body, spores release bacteria that produce toxins causing illness.
Transmission can occur through inhalation, ingestion, or skin cuts, leading to distinct symptoms. Skin exposure leads to itchy blisters or painless sores with swelling. Ingesting contaminated items may result in fever, swollen neck or glands, nausea, vomiting (possibly bloody), diarrhoea, headache, and red eyes and face. Inhalation poses the highest risk, causing flu-like symptoms, breathlessness, coughing blood, and severe outcomes like meningitis. Injection anthrax from heroin use triggers itchy blisters, fever, ulcers, pus pockets, and potential organ failure. Diagnosis involves blood tests for antibodies or toxins. Samples from skin, spinal fluid, stool, and mucus are examined. Imaging and chest X-rays assist in inhalation cases. Treatment hinges on exposure type and includes antibiotics and antitoxins like obiltoxaximab or raxibacumab, particularly for inhalation of anthrax. Severe cases necessitate hospitalization. The anthrax vaccine is advised for at-risk groups such as lab and military personnel and those working with animals. Although not standard after exposure, emergencies may call for vaccination and antibiotics in potential terrorism scenarios.
FutureWise Market Research has published a report that provides an insightful analysis of Anthrax Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that Anthrax Treatment Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.